Chemoinformaics analysis of 1,2,3-Trimethylcyclohexane
| Molecular Weight | 126.243 | nRot | 0 |
| Heavy Atom Molecular Weight | 108.099 | nRig | 6 |
| Exact Molecular Weight | 126.141 | nRing | 1 |
| Solubility: LogS | -4.696 | nHRing | 0 |
| Solubility: LogP | 4.086 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 27.0323 |
| nHD | 0 | BPOL | 18.0577 |
| QED | 0.468 |
| Synth | 2.858 |
| Natural Product Likeliness | 0.817 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.339 |
| MDCK | 0.0000142 |
| BBB | 0.825 |
| PPB | 0.947175 |
| VDSS | 2.069 |
| FU | 0.0444288 |
| CYP1A2-inh | 0.743 |
| CYP1A2-sub | 0.818 |
| CYP2c19-inh | 0.12 |
| CYP2c19-sub | 0.902 |
| CYP2c9-inh | 0.37 |
| CYP2c9-sub | 0.268 |
| CYP2d6-inh | 0.02 |
| CYP2d6-sub | 0.239 |
| CYP3a4-inh | 0.16 |
| CYP3a4-sub | 0.466 |
| CL | 11.526 |
| T12 | 0.158 |
| hERG | 0.015 |
| Ames | 0.048 |
| ROA | 0.045 |
| SkinSen | 0.395 |
| Carcinogencity | 0.116 |
| EI | 0.99 |
| Respiratory | 0.391 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.942591 |